ES2088053T3 - Medicamento y empleo del mismo para el tratamiento de estados de excitacion y disfunciones nerviosas. - Google Patents

Medicamento y empleo del mismo para el tratamiento de estados de excitacion y disfunciones nerviosas.

Info

Publication number
ES2088053T3
ES2088053T3 ES92111709T ES92111709T ES2088053T3 ES 2088053 T3 ES2088053 T3 ES 2088053T3 ES 92111709 T ES92111709 T ES 92111709T ES 92111709 T ES92111709 T ES 92111709T ES 2088053 T3 ES2088053 T3 ES 2088053T3
Authority
ES
Spain
Prior art keywords
excitation
states
treatment
same
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92111709T
Other languages
English (en)
Spanish (es)
Inventor
Werner Dr Schneider
Erich F Prof Dr Elstner
Elisabeth Dr Kleber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk GmbH filed Critical Steigerwald Arzneimittelwerk GmbH
Application granted granted Critical
Publication of ES2088053T3 publication Critical patent/ES2088053T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES92111709T 1991-07-09 1992-07-09 Medicamento y empleo del mismo para el tratamiento de estados de excitacion y disfunciones nerviosas. Expired - Lifetime ES2088053T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4122706A DE4122706C1 (cg-RX-API-DMAC7.html) 1991-07-09 1991-07-09

Publications (1)

Publication Number Publication Date
ES2088053T3 true ES2088053T3 (es) 1996-08-01

Family

ID=6435763

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92111709T Expired - Lifetime ES2088053T3 (es) 1991-07-09 1992-07-09 Medicamento y empleo del mismo para el tratamiento de estados de excitacion y disfunciones nerviosas.

Country Status (26)

Country Link
US (1) US5308619A (cg-RX-API-DMAC7.html)
EP (1) EP0535317B1 (cg-RX-API-DMAC7.html)
JP (1) JPH085796B2 (cg-RX-API-DMAC7.html)
KR (1) KR100225010B1 (cg-RX-API-DMAC7.html)
AT (1) ATE139446T1 (cg-RX-API-DMAC7.html)
AU (1) AU652262B2 (cg-RX-API-DMAC7.html)
CA (1) CA2072950A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ279915B6 (cg-RX-API-DMAC7.html)
DE (2) DE4122706C1 (cg-RX-API-DMAC7.html)
DK (1) DK0535317T3 (cg-RX-API-DMAC7.html)
EE (1) EE03169B1 (cg-RX-API-DMAC7.html)
EG (1) EG20140A (cg-RX-API-DMAC7.html)
ES (1) ES2088053T3 (cg-RX-API-DMAC7.html)
GR (1) GR3020289T3 (cg-RX-API-DMAC7.html)
HU (1) HUT61668A (cg-RX-API-DMAC7.html)
IE (1) IE74691B1 (cg-RX-API-DMAC7.html)
IL (1) IL102410A (cg-RX-API-DMAC7.html)
MD (1) MD1139G2 (cg-RX-API-DMAC7.html)
MX (1) MX9204011A (cg-RX-API-DMAC7.html)
PT (1) PT100668B (cg-RX-API-DMAC7.html)
RU (1) RU2072859C1 (cg-RX-API-DMAC7.html)
SI (1) SI9200138A (cg-RX-API-DMAC7.html)
SK (1) SK279531B6 (cg-RX-API-DMAC7.html)
UA (1) UA26971C2 (cg-RX-API-DMAC7.html)
YU (1) YU48554B (cg-RX-API-DMAC7.html)
ZA (1) ZA925059B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460819A (en) * 1991-12-13 1995-10-24 Children's Medical Center Corporation Method for treating PQQ-responsive heavy metal toxicity
FR2743721B1 (fr) * 1996-01-19 1998-04-03 Innothera Lab Sa Association mineralo-phytotherapique sous forme galenique unitaire de comprimes
DE69943415D1 (de) * 1998-03-26 2011-06-16 Phytopharm Plc Godmanchester Sarsasapogenin und Smilagenin zur Behandlung kognitiver Störungen
BR0010379A (pt) 1999-03-11 2001-12-26 Dan Verser Processo para a produção de etanol
US7074603B2 (en) * 1999-03-11 2006-07-11 Zeachem, Inc. Process for producing ethanol from corn dry milling
US6521634B2 (en) 2001-03-28 2003-02-18 The Hong Kong University Of Science & Technology Uses of dl-THP
KR20030063735A (ko) * 2002-01-23 2003-07-31 주식회사 석산터메디칼 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법
US7341745B2 (en) * 2003-02-07 2008-03-11 Arizona Health Consulting, Llc Method for decreasing nicotine and other substance use in humans
NZ586246A (en) * 2004-01-29 2013-03-28 Zeachem Inc Recovery of organic acids from a fermentation broth
FR2878163B1 (fr) * 2004-11-25 2007-04-27 R & D Pharma Nouvelles compositions pharmaceutiques a visee phytotherapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961M (cg-RX-API-DMAC7.html) * 1961-03-03 1961-11-27
DE1467868A1 (de) * 1964-10-20 1969-01-30 Dainippon Pharmaceutical Co Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes
JPS60181023A (ja) * 1984-02-28 1985-09-14 Nitto Electric Ind Co Ltd 漢方局所麻酔性組成物

Also Published As

Publication number Publication date
RU2072859C1 (ru) 1997-02-10
IE922226A1 (en) 1993-01-13
MD950171A (en) 1996-06-28
IL102410A0 (en) 1993-01-14
KR100225010B1 (ko) 1999-10-15
JPH0753392A (ja) 1995-02-28
PT100668B (pt) 1999-08-31
MD1139G2 (ro) 1999-10-31
IL102410A (en) 1998-02-22
UA26971C2 (uk) 2000-02-28
EG20140A (en) 1997-07-31
SK214392A3 (en) 1994-11-09
ATE139446T1 (de) 1996-07-15
US5308619A (en) 1994-05-03
DK0535317T3 (da) 1996-07-15
DE59206608D1 (de) 1996-07-25
YU48554B (sh) 1998-11-05
MD1139F2 (en) 1999-01-31
HUT61668A (en) 1993-03-01
GR3020289T3 (en) 1996-09-30
JPH085796B2 (ja) 1996-01-24
ZA925059B (en) 1993-04-28
KR930001926A (ko) 1993-02-22
IE74691B1 (en) 1997-07-30
EE03169B1 (et) 1999-04-15
EP0535317B1 (de) 1996-06-19
PT100668A (pt) 1993-09-30
CZ214392A3 (en) 1993-02-17
CZ279915B6 (cs) 1995-08-16
AU1937092A (en) 1993-01-14
AU652262B2 (en) 1994-08-18
MX9204011A (es) 1993-07-01
SI9200138A (en) 1993-03-31
HU9202274D0 (en) 1992-10-28
EP0535317A1 (de) 1993-04-07
DE4122706C1 (cg-RX-API-DMAC7.html) 1993-03-04
CA2072950A1 (en) 1993-01-10
SK279531B6 (sk) 1998-12-02
YU67492A (sr) 1996-01-09

Similar Documents

Publication Publication Date Title
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
UY23992A1 (es) Procedimiento para la preparación de compuestos de 1-fenil-3-dimetilamino-propano
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
AR025960A1 (es) Biblioteca de sustancias que contiene imidazo-5-il-aminas biciclicas y/o imidazo 3-il-aminas biciclicas, procedimiento para la preparacion de estabiblioteca de sustancias, y uso de sustancias de esta biblioteca para la preparacion de medicamentos para el tratamiento del dolor
AR004134A1 (es) Derivados 2-amino-6-anilino-purina y procedimiento y nuevos intermediarios para su preparacion, formulaciones farmaceuticas que comprenden talesderivados y el uso de estos derivados como medicamentos.
AR012172A2 (es) Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento
ES2191187T3 (es) Compuestos heteroaromaticos biciclicos como inhibidores de la proteina tirosin-quinasa.
ES2182161T3 (es) Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
SV1995000002A (es) Uso y obtencion de derivados tetraciclicos ref. 1233cv/vs
SV1999000049A (es) Nuevas dihidropirimidinas 2 heterociclicamente sustituidas ref. lea 32793-sv
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
AR024441A1 (es) Agonistas del receptor a2a n-pirazol, composiciones farmaceuticas y el uso de los mismos para preparar un medicamento.
ES2074513T3 (es) Utilizacion de un antagonista opiaceo para la preparacion de una composicion farmaceutica para administracion transdermica y dispositivo para el suministro percutaneo.
ES2052629T3 (es) Pirazolo(3,4-d)piridinas, procedimiento para su preparacion y utilizacion como medicamentos.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2088053T3 (es) Medicamento y empleo del mismo para el tratamiento de estados de excitacion y disfunciones nerviosas.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ES2113898T3 (es) Compuestos de imidazol, su fabricacion y utilizacion.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2137353T3 (es) Nuevos derivados esteroides especificos del colon o del ileon.
ES2091183T3 (es) Metodo para mejorar el sueño.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 535317

Country of ref document: ES